Refreshing results…
The PTPN2/PTPN1 inhibitor ABBV-CLS-484 unleashes potent anti-tumour immunity
UploadSalvage of ribose from uridine or RNA supports glycolysis in nutrient-limited conditions
UploadSystematic identification of biomarker-driven drug combinations to overcome resistance
UploadINK4 Tumor Suppressor Proteins Mediate Resistance to CDK4/6 Kinase Inhibitors
UploadRhabdoid Tumors Are Sensitive to the Protein-Translation Inhibitor Homoharringtonine
Download from aacrjournals.orgDiscovering the anticancer potential of non-oncology drugs by systematic viability profiling
Download from www.nature.comMissing publications? Search for publications with a matching author name.